After receiving radiation therapy for uterine cancer, you may experience fertility challenges, vaginal dryness, and bowel or bladder problems. Options to manage and relieve your side effects can vary.

Recent studies highlight the effectiveness of lenvatinib and pembrolizumab in improving overall survival for patients with ...

Please provide your email address to receive an email when new articles are posted on . Relugolix combination therapy resulted in reduced heavy menstrual bleeding for 82.9% of Black women with uterine ...

Struggling with distressing menopause symptoms? So many of us are. In a 2023 survey, 81 percent of menopausal and ...

Please provide your email address to receive an email when new articles are posted on . More women in the relugolix group maintained menstrual blood loss volume less than 80 mL vs. placebo. More women ...

(Reuters) - Myovant Sciences Ltd said on Tuesday its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids. The company said 73.4% of women ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...

Safety and efficacy of Scrambler therapy for cancer pain. Background: Neoadjuvant radiation therapy is standard in the management of locally advanced ano-rectal cancer. Laparoscopic ovarian ...

Hundreds of women with advanced uterine cancer in England will be offered a new treatment option from today, NHS England announced. The combination therapy was initially rejected in draft guidance by ...

For many women undergoing fertility treatment, the biggest barrier is not embryo quality but the uterus's ability to accept and support a pregnancy. A thin or unresponsive endometrium (the innermost ...